Antimicrobial Therapy Against Staphylococcus Aureus, Pseudomonas Aeruginosa, and Pseudomonas Cepacia

Chest. 1988 Aug;94(2 Suppl):140S-145S. doi: 10.1378/chest.94.2_supplement.140s.

Abstract

The aims of antimicrobial therapy extend beyond short-term bacterial killing to long-term maintenance of weight and lung function. A review of antimicrobial drug trials shows that empiricism is still ahead of science and more studies are needed both to justify current practice and to make future changes logical.

Publication types

  • Clinical Trial

MeSH terms

  • Anti-Bacterial Agents / therapeutic use*
  • Clinical Trials as Topic
  • Cystic Fibrosis / complications*
  • Humans
  • Lung Diseases / complications
  • Lung Diseases / drug therapy*
  • Pseudomonas Infections / drug therapy*
  • Respiratory Tract Infections / complications
  • Respiratory Tract Infections / drug therapy*
  • Staphylococcal Infections / drug therapy*

Substances

  • Anti-Bacterial Agents